# OnCo record qlh12016 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/qlh12016/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "qlh12016" ;
  schema:name "QLH12016"@en ;
  schema:description "QLH12016 is an experimental protein degrader from Qilu Pharmaceutical in phase 2 trials for prostate cancer, aimed at Androgen receptor."@en ;
  schema:url <https://onco.cc/drugs/qlh12016/> ;
  schema:dateModified "2026-09-11"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/search?intr=QLH12016>, <https://www.qilu-pharma.com> ;
  onco:status "phase-2" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "protein degrader" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:companies <https://onco.cc/companies/qilu-pharmaceutical/> ;
  onco:trials <https://onco.cc/trials/nct07198633/> .